Chen Ankri
Overview
Explore the profile of Chen Ankri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
309
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ankri C, Hershkovitz O, Hershkovitz L, Brami M, Levy R, Sarig H, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543320
Apoptotic cells possess immunomodulatory effects that can be utilized to treat imbalanced immune conditions. Information on the preclinical safety of such treatment is sparse. In this study, the safety of...
2.
Toledano Zur R, Adler G, Shamalov K, Tal Y, Ankri C, Cohen C
Exp Suppl
. 2022 Feb;
113:253-294.
PMID: 35165867
As an important part of the immune system, T lymphocytes exhibit undoubtedly an important role in targeting and eradicating cancer. However, despite these characteristics, their natural antitumor response may be...
3.
Cohen C, Gartner J, Horovitz-Fried M, Shamalov K, Trebska-McGowan K, Bliskovsky V, et al.
J Clin Invest
. 2015 Sep;
125(10):3981-91.
PMID: 26389673
Adoptively transferred tumor-infiltrating T lymphocytes (TILs) that mediate complete regression of metastatic melanoma have been shown to recognize mutated epitopes expressed by autologous tumors. Here, in an attempt to develop...
4.
Ankri C, Cohen C
Oncoimmunology
. 2014 Apr;
3(1):e27399.
PMID: 24711957
Programmed cell death 1 (PDCD1, best known as PD-1) is a central negative regulator of effector T cells that is involved in the etiology of chronic inflammatory conditions, viral diseases,...
5.
Ankri C, Shamalov K, Horovitz-Fried M, Mauer S, Cohen C
J Immunol
. 2013 Sep;
191(8):4121-9.
PMID: 24026081
Adoptive transfer of T cells genetically modified to express cancer-specific receptors can mediate impressive tumor regression in terminally ill patients. However, T cell function and persistence over time could be...
6.
Daniel-Meshulam I, Yaakobi S, Ankri C, Cohen C
Front Immunol
. 2012 Jul;
3:186.
PMID: 22783259
T-cells are central players in the immune response against both pathogens and cancer. Their specificity is solely dictated by the T-cell receptor (TCR) they clonally express. As such, the genetic...